Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Smith

Showing results (301-310 of 327) with videos related to

Pageof 33
Sort By:
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Protein Science : a Publication of the Protein Society|January 1, 1994
Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitorsG M Smith, R S Alexander, D W Christianson, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|January 23, 2020
Topographical classification of dose distributions: implications for control for worker exposureYu Bragin, K Chizhov, M K Sneve, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 26, 2014
3D simulation as a tool for improving the safety culture during remediation work at Andreeva BayK Chizhov, M K Sneve, I Szőke, et al.
Biochemical Society Transactions|December 1, 1984
Renin inhibitors containing 2-substituted statineD F Veber, M G Bock, S F Brady, et al.
British Journal of Haematology|February 13, 2001
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myelomaG Pratt, J A Fenton, F E Davies, et al.
Journal of Medicinal Chemistry|August 1, 1984
Structure-activity, theoretical, and X-ray studies on the intramolecular interactions in a series of novel histamine H2 receptor antagonistsW C Lumma, J J Baldwin, J B Bicking, et al.
Journal of Medicinal Chemistry|April 1, 1987
Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11- dicarboxylates as calcium entry antagonists: new conformationally restrained analogues of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformationJ J Baldwin, D A Claremon, P K Lumma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaE M Bessell, A Burton, A P Haynes, et al.
Bone Marrow Transplantation|May 1, 1996
Peripheral blood stem cell transplantation in myeloma using CD34 selected cellsR J Johnson, R G Owen, G M Smith, et al.
Pageof 33

Showing results (301-310 of 327) with videos related to

Sort By:
Pageof 33
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Protein Science : a Publication of the Protein Society|January 1, 1994
Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitorsG M Smith, R S Alexander, D W Christianson, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|January 23, 2020
Topographical classification of dose distributions: implications for control for worker exposureYu Bragin, K Chizhov, M K Sneve, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 26, 2014
3D simulation as a tool for improving the safety culture during remediation work at Andreeva BayK Chizhov, M K Sneve, I Szőke, et al.
Biochemical Society Transactions|December 1, 1984
Renin inhibitors containing 2-substituted statineD F Veber, M G Bock, S F Brady, et al.
British Journal of Haematology|February 13, 2001
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myelomaG Pratt, J A Fenton, F E Davies, et al.
Journal of Medicinal Chemistry|August 1, 1984
Structure-activity, theoretical, and X-ray studies on the intramolecular interactions in a series of novel histamine H2 receptor antagonistsW C Lumma, J J Baldwin, J B Bicking, et al.
Journal of Medicinal Chemistry|April 1, 1987
Diethyl 3,6-dihydro-2,4-dimethyl-2,6-methano-1,3-benzothiazocine-5,11- dicarboxylates as calcium entry antagonists: new conformationally restrained analogues of Hantzsch 1,4-dihydropyridines related to nitrendipine as probes for receptor-site conformationJ J Baldwin, D A Claremon, P K Lumma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaE M Bessell, A Burton, A P Haynes, et al.
Bone Marrow Transplantation|May 1, 1996
Peripheral blood stem cell transplantation in myeloma using CD34 selected cellsR J Johnson, R G Owen, G M Smith, et al.
Pageof 33